Spinal and peripheral analgesic effects of the CB2 cannabinoid receptor agonist AM1241 in two models of bone cancer-induced pain 22 Nov Dr D Central and peripheral sites of action for CB2 receptor mediated analgesic activity in chronic inflammatory and neuropathic pain models in rats Cannabinoid CB2 receptor-mediated anti-nociception in models of acute and chronic pain.